Menu

Karen Deschaine

Partner

I wake up each morning excited to help our clients grow their businesses.

kdeschaine@cooley.com

Karen’s practice encompasses a wide range of business and corporate matters, including private financings, public offerings, corporate governance, commercial transactions, strategic transactions, securities matters, and the general representation of public and private companies. She primarily represents biotechnology and technology companies and investors in those industries. She is a sought-after speaker on topics of interest to founders, public companies and companies seeking investment, and she has presented for organizations and events such as GeekGirlCon, Veterans in Economic Transition Conference (VETCON), Association of Corporate Counsel – San Diego, Women In Bio, BioMedSA and the Women’s Venture Summit.

Download full bio 

Experience

  • Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion 

  • Talis Biomedical – $254 Million IPO 

  • Metacrine – $85 Million IPO 

  • Novo Holdings Leads $72 Million Series E for LanzaTech 

  • Castle Biosciences $74 Million IPO 

  • View all

Passions

    Snowboarding

    Travel

    Cooking

    Spending time with family and friends

Education

  • University of California at Los Angeles School of Law
    JD, Business Law
    2007

  • Auburn University
    MBA, 2001

  • United States Military Academy
    BS, Economics
    1997


Admissions & Credentials

California

Memberships

  • American Bar Association

  • State Bar of California

  • Lawyers Club of San Diego

Rankings & Accolades

    Athena San Diego: Pinnacle Award (2009)

    San Diego Daily Transcript: Young Attorneys (2009)

    SD Metro magazine: "40 Under 40" (2011)

    San Diego Business Journal: "Women Who Mean Business" (2011)

    SD Metro magazine: "Women Who Impact San Diego" (2014)